Physician Resources: Surgical Oncology Rounds Summer 2019
- Dr. Amer Zureikat describes Neoadjuvant treatment of resectable and borderline resectable pancreatic head adenocarcinoma. He also discusses if FOLFIRINOX is better than Gemcitabine/Nab-Paclitaxel.
- Dr. David Geller provides an update on liver surgical oncology programs at UPMC and reviews the most common tumors treated.
- Dr. Haroon Choudry provides a conceptual background and rationale for CRS-IPC that may help optimize patient selection for locoregional treatment modality.
- Drs. Reema Mallick, Ashok Muthukrishnan, Jannat Malik, and Kelly McCoy present findings on SPECT-CT Tc-99 Sestamibi Imaging for Primary Hyperparathyroidism.
- Dr. Emilia Diego discusses eliminating surgery in breast cancer treatment and reviews Dr. Bernard Fisher’s work of de-escalating cancer care.
Upon completion of this activity, participants should be able to:
- Explain adjuvant therapy vs. neoadjuvant therapy for pancreatic ductal carcinoma
- Describe the factors that influence patient selection for cytoreductive surgery with hyperthermic intraperitoneal chemoperfusion
Amer H. Zureikat, MD, Division of Surgical Oncology
David A. Geller, MD, Richard L Simmons Professor of Surgery at the University of Pittsburgh School of Medicine, Co-Director of the UPMC Liver Cancer Center
M. Haroon Asif Choudry, Surgical Oncologist at UPMC Cancer Center and Assistant Professor of Surgery and Surgical Oncology at the University of Pittsburgh
Kelly McCoy, MD, Associate Professor of Surgery
Emilia Diego, MD, Division of Surgical Oncology Magee-Womens Surgical Associates Office
Drs. Haroon A. Choudry, David Geller, Jannat Malik, Reema Mallick, Kelly L. McCoy, Ashok Muthukrishnan, Amer Zureikat has reported no relevant relationships with entities producing health care goods or services.
Dr. Emilia Diego has financial interests with the following entity or entities producing health care goods or services as indicated below:
- Other: DSMB Xoft, Inc.
All presenters disclosure of relevant financial relationships with any entity producing, marketing, re-selling, or distributing health care goods or services, used on, or consumed by, patients is listed above. No other planners, members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships to disclose.
The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The University of Pittsburgh School of Medicine designates this enduring material for a maximum of .50 AMA PRA Category 1 Credits. Each physician should only claim credit commensurate with the extent of their participation in the activity. Other health care professionals are awarded (.05) continuing education units (CEU) which are equivalent to .50 contact hour.
- 0.50 AMA PRA Category 1 Credit™The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
- 0.50 Attendance